Home › Prostate Cancer › Washington › Tacoma
Prostate Cancer clinical trials in Tacoma, WA
11 studies for Prostate Cancer are looking for participants at sites in and around Tacoma (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
RecruitingPhase 3
- Providence Regional Cancer System-Lacey, Lacey · 23 mi away
The Vanguard Study: Testing a New Way to Screen for Cancer
RecruitingHealthy volunteers welcome
- Madigan Army Medical Center, Tacoma
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Providence Regional Cancer System-Lacey, Lacey · 23 mi away
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
RecruitingPhase 3
- Northwest Medical Specialties, PLLC, Tacoma
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
RecruitingPhase 3
- Research Site, Tacoma
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
RecruitingPhase 3
- Northwest Medical Specialties, Tacoma
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
RecruitingPhase 3
- Northwest Medical Specialties, PLLC, Tacoma
- Northwest Medical Specialties, PLLC, Gig Harbor · 8 mi away
- Northwest Medical Specialties, PLLC, Puyallup · 8 mi away
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
RecruitingPhase 2
- Northwest Medical Specialties, PLLC - Tacoma, Tacoma
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
RecruitingPhase 3
- Providence Regional Cancer System-Lacey, Lacey · 23 mi away
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
RecruitingPhase 1
- Northwest Medical Specialties, Tacoma
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
RecruitingPhase 2
- Providence Regional Cancer System-Yelm, Yelm · 23 mi away
- Providence Regional Cancer System-Lacey, Lacey · 23 mi away
About Prostate Cancer
Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.
More about Prostate Cancer on MedlinePlus
Prostate Cancer trials in other cities
- New York City, NY101 studies
- Houston, TX73 studies
- Los Angeles, CA64 studies
- Boston, MA56 studies
- Seattle, WA45 studies
- St. Louis, MO45 studies
- Chicago, IL45 studies
- Baltimore, MD45 studies
- San Francisco, CA44 studies
- Philadelphia, PA41 studies
- Nashville, TN40 studies
- Washington, DC39 studies
Other studies in Tacoma
- Non-Small Cell Lung Cancer18 studies
- Breast Cancer17 studies
- Multiple Myeloma13 studies
- Ulcerative Colitis13 studies
- Metastatic Cancer10 studies
- Crohn's Disease10 studies
- Colorectal Cancer10 studies
- Ovarian Cancer7 studies
- Melanoma7 studies
- Cancer (all types)6 studies
- Stomach Cancer6 studies
- Pancreatic Cancer6 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.